Skip to main content

MoneyWorks4Me

Venus Remedies informs about press release

25 Feb 2025 Evaluate
Venus Remedies has informed that it enclosed a press release titled ‘Venus Remedies secures exclusive In-Licensing rights from Infex Therapeutics to develop and commercialize MET-X in India’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1872.30
Dr. Reddys Labs. 1396.00
Cipla 1420.00
Lupin 1968.95
Zydus Lifesciences 1195.00
View more..